Primex News International

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    India’s Conscious Consumers Choose ACTIZEET as the Best Essential Oil Brand

    July 31, 2025

    Sid Sriram Announces His First-Ever India Tour in 2025 – A Landmark Musical Homecoming Across Bengaluru, Chennai, and Hyderabad

    July 31, 2025

    AGL To Strengthen Its Hold in Building Materials Sector Supporting Its Vision for Future Growth

    July 31, 2025
    Facebook Twitter Instagram
    Primex News International
    • Home
    Facebook Twitter Instagram
    Primex News International
    Home»Business»Fredun Pharmaceuticals Net Profit Rises 64% YoY in Q1 FY26
    Business

    Fredun Pharmaceuticals Net Profit Rises 64% YoY in Q1 FY26

    Mohit ReddyBy Mohit ReddyJuly 31, 2025No Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email

    Mumbai (Maharashtra) [India], July 31: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), is one of the Leading Pharmaceuticals Formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility and Animal Healthcare Products, has reported its Unaudited financials for Q1 FY26.

    Key Financial Highlights 

    Particulars (₹ Cr) Q1 FY26 Q1 FY25 YoY
    Total Income 119.86 78.81 52.08%
    EBITDA 16.99 10.48 62.15%
    EBITDA Margin (%) 14.18 13.30 88 BPS
    Net Profit 6.77 4.13 63.82%
    Net Profit Margin (%) 5.64 5.24 40 BPS
    Diluted EPS (₹) 14.33 8.79 63.03%

    Commenting on the financial performance Mr. Fredun Medhora, Managing Director, said “We are pleased to report a strong start to FY26 with a significant year-on-year growth in net profit and healthy improvement across all key financial metrics. Our performance reflects the successful execution of our growth strategy and the continued demand for our diversified portfolio across domestic and international markets. Our generics portfolio continues to strengthen, with over 1,200 products currently under registration. Our current order book stands at over ₹200 crore, providing strong revenue visibility and momentum for the upcoming quarters.

    We have entered the organized pet care market with the acquisition of a controlling stake in One Pet Stop through our subsidiary FRPL, giving us access to a loyal customer base and a tech-enabled, doorstep grooming service. This move complements our premium Freossi pet care range and strengthens our vision to grow as a holistic player in India’s rapidly expanding pet wellness space.

    The pharmaceutical and healthcare industry continues to see robust demand driven by increasing health awareness, focus on affordable care, and supportive regulatory frameworks. With our growing presence in generics, cosmeceuticals, nutraceuticals, mobility aids, and animal health products, we are well-positioned to capitalize on these opportunities. Looking ahead, we remain committed to enhancing value through consistent performance, product innovation, and expanding our global reach.”

    Q1 FY26 Key Business Highlights

    Upgrade in Credit Rating
    • Rating Upgrade:
    • Long-term rating upgraded to IVR BBB/Stable (from IVR BBB-/Stable)
    • Assigned IVR BBB/Stable / IVR A3+ for long/short-term facilities
    • Total amount rated: ₹139.64 Cr
    Acquisition of One Pet Stop
    • Entity Involved: Fredun Retail Pvt. Ltd. (FRPL), a wholly owned subsidiary.
    • Acquisition: FPRL acquires controlling stake in One Pet Stop Pvt. Ltd.

    If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Mohit Reddy
    • Website

    Related Posts

    India’s Conscious Consumers Choose ACTIZEET as the Best Essential Oil Brand

    July 31, 2025

    AGL To Strengthen Its Hold in Building Materials Sector Supporting Its Vision for Future Growth

    July 31, 2025

    Jyoti Global Plast Limited to raise up to Rs. 35.44 crore from Public Issue; IPO opens on August 4

    July 31, 2025

    Eco Recycling Reports Rs 8 Cr PAT, up 268 Percent in Consolidated Q1 FY26

    July 30, 2025

    Aayush Wellness Announces 2nd Interim Dividend

    July 30, 2025

    How Vivanta Stays Is Quietly Shaking Up India’s Luxury Villa Market With Heart and Hustle

    July 30, 2025

    Comments are closed.

    Top Reviews
    Editors Picks

    India’s Conscious Consumers Choose ACTIZEET as the Best Essential Oil Brand

    July 31, 2025

    Sid Sriram Announces His First-Ever India Tour in 2025 – A Landmark Musical Homecoming Across Bengaluru, Chennai, and Hyderabad

    July 31, 2025

    AGL To Strengthen Its Hold in Building Materials Sector Supporting Its Vision for Future Growth

    July 31, 2025

    Kumar Sanu’s Musical Legacy Echoes in Sanjay Bedia’s Latest Teaser Launch of ‘Haay Mera Dil’

    July 31, 2025
    About Us
    About Us
    Our Picks

    India’s Conscious Consumers Choose ACTIZEET as the Best Essential Oil Brand

    July 31, 2025

    Sid Sriram Announces His First-Ever India Tour in 2025 – A Landmark Musical Homecoming Across Bengaluru, Chennai, and Hyderabad

    July 31, 2025

    AGL To Strengthen Its Hold in Building Materials Sector Supporting Its Vision for Future Growth

    July 31, 2025
    Top Reviews
    © 2025 Primex News International. Designed by Primex Media Services.
    • Home

    Type above and press Enter to search. Press Esc to cancel.